Search Results "#PeproMene"

Posted by Ben Gross on September 12 2023 at 04:31 AM   public
PeproMene Bio, Inc., a clinical-stage biotech company, has announced the successful completion of the first dose cohort in its phase 1 clinical trial for PMB-CT01 (BAFFR-CAR T Cells), a novel the...